- Investing Ideas
- /
- Hong Kong Healthcare Global Supply Chain Shortage
Hong Kong Healthcare Global Supply Chain Shortage
Results
19
19 companies
Sinopharm Group
Market Cap: HK$57.4b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$18.40
7D
2.4%
1Y
-14.4%
Guangzhou Baiyunshan Pharmaceutical Holdings
Market Cap: HK$43.8b
Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally.
874
HK$17.04
7D
1.2%
1Y
-25.3%
YSB
Market Cap: HK$5.1b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$7.46
7D
4.5%
1Y
-10.0%
IVD Medical Holding
Market Cap: HK$2.7b
An investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally.
1931
HK$1.67
7D
0.6%
1Y
5.0%
Shanghai Pioneer Holding
Market Cap: HK$2.6b
An investment holding company, engages in marketing, promotion and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China.
1345
HK$2.26
7D
0.4%
1Y
19.6%
Charmacy Pharmaceutical
Market Cap: HK$837.0m
Engages in the pharmaceutical distribution business in the People’s Republic of China.
2289
HK$7.75
7D
0%
1Y
-44.2%
ClouDr Group
Market Cap: HK$715.4m
An investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management.
9955
HK$1.08
7D
-1.8%
1Y
-68.5%
Sinco Pharmaceuticals Holdings
Market Cap: HK$370.0m
An investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China.
6833
HK$0.18
7D
1.7%
1Y
-20.2%
Tycoon Group Holdings
Market Cap: HK$356.0m
An investment holding company, distributes and retails a suite of health and well-being related products in Hong Kong, Mainland China, Macau, Singapore, and internationally.
3390
HK$0.45
7D
-4.3%
1Y
-88.9%
Kingworld Medicines Group
Market Cap: HK$318.4m
An investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products.
1110
HK$0.54
7D
-3.6%
1Y
-6.9%
Guanze Medical Information Industry (Holding)
Market Cap: HK$294.5m
An investment holding company, provides medical imaging solutions in the People’s Republic of China.
2427
HK$0.31
7D
-8.8%
1Y
-66.7%
Yunnan Energy International
Market Cap: HK$192.8m
An investment holding company, distributes analytical and laboratory instruments, and life science equipment in the People’s Republic of China, rest of Asia, and internationally.
1298
HK$0.70
7D
0%
1Y
-36.4%
Tai United Holdings
Market Cap: HK$147.0m
An investment holding company, primarily invests in properties in the People’s Republic of China, Singapore, the United States, the United Kingdom, the Republic of Mongolia, Australia, and Belgium.
718
HK$0.028
7D
0%
1Y
n/a
Grand Brilliance Group Holdings
Market Cap: HK$94.4m
An investment holding company, engages in supplying of medical devices in Hong Kong.
8372
HK$0.12
7D
3.5%
1Y
7.3%
New Ray Medicine International Holding
Market Cap: HK$71.9m
An investment holding company, engages in distribution and trading of injection drugs and pharmaceutical products in the People’s Republic of China.
6108
HK$0.043
7D
-6.5%
1Y
4.9%
China Health Group
Market Cap: HK$68.8m
An investment holding company, engages in the distribution and services of medical equipment and consumables in the People’s Republic of China.
673
HK$0.14
7D
0%
1Y
-84.8%
Universal Health International Group Holding
Market Cap: HK$61.7m
An investment holding company, distributes and retails drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People’s Republic of China.
2211
HK$0.077
7D
-6.1%
1Y
63.8%
Pa Shun International Holdings
Market Cap: HK$44.2m
An investment holding company, engages in the pharmaceutical distribution and manufacturing business in the People’s Republic of China.
574
HK$0.03
7D
0%
1Y
-40.0%
Wanjia Group Holdings
Market Cap: HK$39.2m
An investment holding company, engages in pharmaceutical wholesale and distribution business in the Mainland China and Hong Kong.
401
HK$0.07
7D
-12.5%
1Y
-10.3%